TILT Biotherapeutics in a $25.6 million Series B funding led by EIC Fund, Lifeline Ventures, Finnish Industry Investment TESI, and Stephen Industries
02 May 2025
02 May 2025
Total investments received (USD): 62.39M
Round value (USD): 25.6M
Company: TILT Biotherapeutics
Industry: BiotechHealth services
Related deals
Ketryx closed a $39 million Series B round led by Transformation Capital, joined by Lightspeed Venture, MIT’s E14 Fund, Ubiquity Ventures, and 53 Stations.
Investments
29 August 2025
Omnio in a €30 million debt to equity conversion alongside a new equity issuance with Achilles Capital
Investments
17 August 2025
Anocca raises SEK 440 million in an equity deal ld by Mellby Gård, joined by AMF and Ramsbury in Sweden.
Investments
05 August 2025
Valmet Automotive in a deal with the Finnish state which buys CATL out, controls 79% and invests an extra €37.5M alongside Pontos
Investments
02 August 2025
Cyted Health raises €37.5 million in a Series B financing round led by EQT Life Sciences, Advent Life and British Business Bank, w/ Morningside and BGF.
Investments
01 August 2025
Netherlands
Germany
Switzerland
Denmark
Estonia
Iceland
Latvia
Lithuania
Norway
France
Ireland
Italy
Portugal
Spain